About Us
|
contact Us
|
Sitemap
Call us: +1-855-455-8662
|
Home
Business Solutions
Business Research Reports
Business Consulting
On-site Implementation & Training Programs
Industry Trackers
Subscription Solutions
Industry Reports
News
Press
Login
Register
Home
Therapeutic Area
Veterinary Intravenous (IV) Solutions Market Expected to Grow at 5.5% by 2032
Veterinary Intravenous (IV) Solutions Market By Product (Isotonic crystalloids, Synthetic colloids, Blood products, Dextrose solutions, Parenteral nutrition), By Indication (Diabetic Ketoacidosis, Pancreatitis, Anthrax, Chronic Kidney Disease, Others), By Animal Type (Companion Animals, Production Animals), By End-Use (Veterinary Hospitals, Research Institutes, Others) - Growth, Share, Opportunities & Competitive Analysis, 2024 - 2032
12 Jul 2023
Format
Request Sample
Report Summary
Table of contents
list of tables
list of figures
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Veterinary Intravenous (IV) Solutions Market
2.2. Global Veterinary Intravenous (IV) Solutions Market, By Product, 2023 (US$ Million)
2.3. Global Veterinary Intravenous (IV) Solutions Market, By Indication, 2023 (US$ Million)
2.4. Global Veterinary Intravenous (IV) Solutions Market, By Animal Type, 2023 (US$ Million)
2.5. Global Veterinary Intravenous (IV) Solutions Market, By End-Use, 2023 (US$ Million)
2.6. Global Veterinary Intravenous (IV) Solutions Market, By Geography, 2023 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2023
3. Veterinary Intravenous (IV) Solutions Market: Competitive Analysis
3.1. Market Positioning of Key Veterinary Intravenous (IV) Solutions Market Vendors
3.2. Strategies Adopted by Veterinary Intravenous (IV) Solutions Market Vendors
3.3. Key Industry Strategies
4. Veterinary Intravenous (IV) Solutions Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Veterinary Intravenous (IV) Solutions Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Isotonic crystalloids
5.3.2. Synthetic colloids
5.3.3. Blood products
5.3.4. Dextrose solutions
5.3.5. Parenteral nutrition
6. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Diabetic Ketoacidosis
6.3.2. Pancreatitis
6.3.3. Anthrax
6.3.4. Chronic Kidney Disease
6.3.5. Others
7. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Companion Animals
7.3.2. Production Animals
8. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2023 Versus 2032
8.3. Market Segmentation
8.3.1. Veterinary Hospitals
8.3.2. Research Institutes
8.3.3. Others
9. North America Veterinary Intravenous (IV) Solutions Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
9.3. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
9.4. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
9.5. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
9.6.Veterinary Intravenous (IV) Solutions Market: By Region, 2022-2032, USD (Million)
9.6.1.North America
9.6.1.1. U.S.
9.6.1.1.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
9.6.1.1.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
9.6.1.1.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
9.6.1.1.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
9.6.1.2.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
9.6.1.2.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
9.6.1.2.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
9.6.1.3.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
9.6.1.3.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
9.6.1.3.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
10. UK and European Union Veterinary Intravenous (IV) Solutions Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
10.3. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
10.4. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
10.5. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
10.6.Veterinary Intravenous (IV) Solutions Market: By Region, 2022-2032, USD (Million)
10.6.1.UK and European Union
10.6.1.1. UK
10.6.1.1.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
10.6.1.1.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
10.6.1.1.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
10.6.1.1.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
10.6.1.2.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
10.6.1.2.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
10.6.1.2.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
10.6.1.3.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
10.6.1.3.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
10.6.1.3.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
10.6.1.4.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
10.6.1.4.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
10.6.1.4.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
10.6.1.5. France
10.6.1.5.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
10.6.1.5.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
10.6.1.5.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
10.6.1.5.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
10.6.1.6.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
10.6.1.6.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
10.6.1.6.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
11. Asia Pacific Veterinary Intravenous (IV) Solutions Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
11.3. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
11.4. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
11.5. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
11.6.Veterinary Intravenous (IV) Solutions Market: By Region, 2022-2032, USD (Million)
11.6.1.Asia Pacific
11.6.1.1. China
11.6.1.1.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
11.6.1.1.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
11.6.1.1.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
11.6.1.1.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
11.6.1.2.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
11.6.1.2.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
11.6.1.2.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
11.6.1.3. India
11.6.1.3.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
11.6.1.3.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
11.6.1.3.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
11.6.1.3.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
11.6.1.4.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
11.6.1.4.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
11.6.1.4.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
11.6.1.5.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
11.6.1.5.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
11.6.1.5.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
11.6.1.6.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
11.6.1.6.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
11.6.1.6.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
12. Latin America Veterinary Intravenous (IV) Solutions Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
12.3. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
12.4. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
12.5. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
12.6.Veterinary Intravenous (IV) Solutions Market: By Region, 2022-2032, USD (Million)
12.6.1.Latin America
12.6.1.1. Brazil
12.6.1.1.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
12.6.1.1.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
12.6.1.1.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
12.6.1.1.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
12.6.1.2.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
12.6.1.2.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
12.6.1.2.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
12.6.1.3.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
12.6.1.3.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
12.6.1.3.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
13. Middle East and Africa Veterinary Intravenous (IV) Solutions Market, 2022-2032, USD (Million)
13.1. Market Overview
13.2. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
13.3. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
13.4. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
13.5. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
13.6.Veterinary Intravenous (IV) Solutions Market: By Region, 2022-2032, USD (Million)
13.6.1.Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
13.6.1.1.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
13.6.1.1.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
13.6.1.1.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
13.6.1.2.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
13.6.1.2.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
13.6.1.2.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Veterinary Intravenous (IV) Solutions Market: By Product, 2022-2032, USD (Million)
13.6.1.3.2. Veterinary Intravenous (IV) Solutions Market: By Indication, 2022-2032, USD (Million)
13.6.1.3.3. Veterinary Intravenous (IV) Solutions Market: By Animal Type, 2022-2032, USD (Million)
13.6.1.3.4. Veterinary Intravenous (IV) Solutions Market: By End-Use, 2022-2032, USD (Million)
14. Company Profile
14.1. Zoetis Inc.
14.1.1. Company Overview
14.1.2. Financial Performance
14.1.3. Product Portfolio
14.1.4. Strategic Initiatives
14.2. Bayer Animal Health
14.2.1. Company Overview
14.2.2. Financial Performance
14.2.3. Product Portfolio
14.2.4. Strategic Initiatives
14.3. Merck & Co., Inc.
14.3.1. Company Overview
14.3.2. Financial Performance
14.3.3. Product Portfolio
14.3.4. Strategic Initiatives
14.4. Elanco Animal Health
14.4.1. Company Overview
14.4.2. Financial Performance
14.4.3. Product Portfolio
14.4.4. Strategic Initiatives
14.5. Boehringer Ingelheim Animal Health
14.5.1. Company Overview
14.5.2. Financial Performance
14.5.3. Product Portfolio
14.5.4. Strategic Initiatives
14.6. Dechra Veterinary Products
14.6.1. Company Overview
14.6.2. Financial Performance
14.6.3. Product Portfolio
14.6.4. Strategic Initiatives
14.7. Sypharma
14.7.1. Company Overview
14.7.2. Financial Performance
14.7.3. Product Portfolio
14.7.4. Strategic Initiatives
14.8. Animalcare
14.8.1. Company Overview
14.8.2. Financial Performance
14.8.3. Product Portfolio
14.8.4. Strategic Initiatives
14.9. B. Braun SE
14.9.1. Company Overview
14.9.2. Financial Performance
14.9.3. Product Portfolio
14.9.4. Strategic Initiatives
14.10. Woods Consulting, LLC
14.10.1. Company Overview
14.10.2. Financial Performance
14.10.3. Product Portfolio
14.10.4. Strategic Initiatives
14.11. Baxter
14.11.1. Company Overview
14.11.2. Financial Performance
14.11.3. Product Portfolio
14.11.4. Strategic Initiatives
14.12. Fresenius Kabi
14.12.1. Company Overview
14.12.2. Financial Performance
14.12.3. Product Portfolio
14.12.4. Strategic Initiatives
14.13. Other Notable Players
14.13.1. Company Overview
14.13.2. Financial Performance
14.13.3. Product Portfolio
14.13.4. Strategic Initiatives
Choose Licence Type
Single User Licence
$4500
Multi User license
$6500
Corporate license
$9000
Buy Now
Quick Contact
+1-855-455-8662
+91 77559-81103
sales@acutemarketreports.com
View Other Reports
Automotive
986
Chemicals and Materials
684
Consumer Goods
184
Energy
124
Food & Beverages
321
Medical Devices
178
Pharmaceutical & Healthcare
78
Technology
234